Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease

Neurogenetics. 2008 Oct;9(4):263-9. doi: 10.1007/s10048-008-0138-0. Epub 2008 Aug 15.

Abstract

Mutations in five PARK genes (SNCA, PARKIN, DJ-1, PINK1, and LRRK2) are well-established genetic causes of Parkinson disease (PD). Recently, G2385R substitution in LRRK2 has been determined as a susceptibility allele in Asian PD. The objective of this study is to determine the frequency of mutations in these PARK genes in a Korean early-onset Parkinson disease (EOPD) cohort. The authors sequenced 35 exons in SNCA, PARKIN, DJ-1, PINK1, and LRRK2 in 72 unrelated EOPD (age-at-onset <or=50) recruited from ten movement disorders clinics in South Korea. Gene dosage change of the aforementioned genes was studied using multiple ligation-dependent probe amplification. We found four patients with PARKIN mutations, which were homozygous deletion of exon 4, compound heterozygous deletion of exon 2 and exon 4, heterozygous deletion of exon 4, and heterozygous nonsense mutation (Q40X). Four patients had PINK1 mutations; a compound heterozygous mutation (N367S and K520RfsX522) and three heterozygous mutations (G32R, R279H, and F385L). A missense mutation of SNCA (A53T) was found in a familial PD with autosomal dominant inheritance. Nine patients (12.5%) had heterozygous G2385R polymorphism of LRRK2, whereas none had G2019S mutation. However, no mutations were detected in DJ-1 and UCHL1 in our series. We identified genetic variants in PARKIN, PINK1, LRRK2, and SNCA as a cause or genetic risk factors for PD in 25% of Korean EOPD, and mutation of PARKIN was the most common genetic cause.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Base Sequence
  • Case-Control Studies
  • Cohort Studies
  • DNA Mutational Analysis
  • DNA Primers / genetics
  • Female
  • Gene Dosage
  • Heterozygote
  • Homozygote
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Korea
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Male
  • Middle Aged
  • Mutation*
  • Oncogene Proteins / genetics
  • Parkinson Disease / genetics*
  • Polymerase Chain Reaction
  • Protein Deglycase DJ-1
  • Protein Kinases / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Ubiquitin-Protein Ligases / genetics
  • Young Adult
  • alpha-Synuclein / genetics

Substances

  • DNA Primers
  • Intracellular Signaling Peptides and Proteins
  • Oncogene Proteins
  • SNCA protein, human
  • alpha-Synuclein
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Protein Kinases
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • PTEN-induced putative kinase
  • Protein Serine-Threonine Kinases
  • PARK7 protein, human
  • Protein Deglycase DJ-1